Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine

Abstract

AbstractBackground and ObjectivesThere are high rates of comorbidity between posttraumatic stress disorder (PTSD) and opioid use disorder (OUD). Evidence‐based trauma‐focused psychotherapies such as Cognitive Processing Therapy (CPT) are a first‐line treatment for PTSD. Veterans with OUD are treated primarily in substance use disorder (SUD) clinics where the standard of care is drug counseling; they often do not have access to first‐line PTSD treatments. This study tested whether CPT can be conducted safely and effectively in veterans with comorbid OUD treated with buprenorphine.MethodsThis 12‐week, 2‐site, randomized clinical trial (RCT) included open‐label randomization to two groups: (a) CPT versus (b) Individual Drug Counselling (IDC) in veterans with PTSD and comorbid OUD who were maintained on buprenorphine (N = 38).ResultsVeterans randomized to either IDC (n = 18) or CPT (n = 20) showed a significant reduction in self‐reported PTSD symptoms over time as measured by the PTSD checklist (PCL‐5) but there were no treatment group differences; there was some indication that reduction in PTSD symptoms in the CPT group were sustained in contrast to the IDC group. Recruitment was significantly impacted by COVID‐19 pandemic, so this study serves as a proof‐of‐concept pilot study.Discussion and ConclusionsVeterans with OUD and PTSD can safely and effectively participate in evidence‐based therapy for PTSD; further work should confirm that trauma‐focused treatment may be more effective in leading to sustained remission of PTSD symptoms than drug counseling.Scientific SignificanceThis is the first study to evaluate CPT for PTSD in the context of buprenorphine treatment for OUD.